Please login to the form below
NIH
This page shows the latest NIH news and features for those working in and with pharma, biotech and healthcare.
American Medical Association calls for COVID-19 vaccine development transparency
In a call with reporters earlier this month, US National Institutes of Health (NIH) Director Francis Collins tried to soothe some of these concerns by maintaining that regulatory approval for a
Latest news
-
US payments for COVID-19 vaccines tied to specific timing milestones
To quash some of those concerns, US National Institutes of Health (NIH) Director Francis Collins recently said regulatory approval for any potential COVID-19 vaccine included in the government’s Operation
-
COVID-19 vaccine approval unlikely before November, says US NIH director
US National Institutes of Health (NIH) Director Francis Collins said regulatory approval for any potential COVID-19 vaccine included in the government’s Operation Warp Speed is unlikely to occur before
-
Moderna’s COVID-19 vaccine enters pivotal phase 3 trial
Moderna and the US National Institutes of Health (NIH) are collaborating on the late-stage COVE trial, which will evaluate the vaccine in 30, 000 study participants.
-
Moderna clashes with US scientists over pivotal COVID-19 vaccine trials
No one has ever done anything like this before – not Moderna, not the NIH and not any of the other companies.”.
-
Gilead halts individual requests for COVID-19 hopeful remdesivir
The pharma giant is already collaborating with the US National Institutes of Health (NIH) on a clinical trial of remdesivir as a treatment for seriously ill COVID-19 patients. ... The NIH trial is enrolling up to 1, 000 patients to receive treatment with
More from news
Approximately 7 fully matching, plus 74 partially matching documents found.
Latest Intelligence
-
Developing a COVID-19 vaccine
The phase 1 study, which is being conducted by the US National Institutes of Health (NIH) at Kaiser Permanente Washington Health Research Institute in Seattle, aims to recruit 45 healthy men
-
As COVID-19 takes over the world, biopharma fights back
Lane is currently overseeing ongoing studies at the US National Institutes of Health (NIH), including its remdesivir study.
-
Driving the innovation engine
key. Cultural adoption is another goal. NIH (Not Invented Here) Syndrome is a fact of life in organisations large and small.
-
Streamlining clinical trials – why better data use is key
Today, CTTI is building on this work by collaborating with an NIH workgroup to develop a comprehensive plan for assessing the NIH’s sIRB policy, and by developing resources to assist
-
SEO for the healthcare industry
Frequently, the leader for UK searches is www.NHS.uk/conditions while www.webmd.com, www.cdc.gov, www.mayoclinic.org and http://www.ncbi.nlm.nih.gov/ are big hitters
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences
Shailubhai has also previously served at Callisto Pharmaceuticals, Monsanto Company and as a senior staff fellow at the National Institutes of Health (NIH).
-
Sanofi names CSO Gary Nabel to Ebola role
Elias Zerhouni, president of Sanofi global research and development, said: “Given his past experience in public health epidemics as director of the NIH vaccine research centre and his leadership in developing ... an Ebola vaccine at NIH, Dr Nabel is
-
Former Pfizer exec Stephen Williams joins Venaxis board
run by the Foundation for NIH from 2005-2007.
-
Eric Green named NIH's data science lead
NIH). Dr Green takes the role on an interim basis while the NIH attempts to find someone to take on the position on a permanent basis to lead its efforts to ... Dr Green has been director of the NHGRI since 2009, having previously served as scientific
-
Sanofi appoints NIH’s Gary Nabel as chief scientific officer
Dr Gary Nabel has left US medical research centre the National Institutes of Health (NIH) to join Sanofi as senior VP, chief scientific officer and deputy to the president for global ... Dr Nabel leaves the NIH, which is part of the US government's
More from appointments
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
If our patients are diverse, why are clinical trials so white?
https://www.cdc.gov/cancer/skin/statistics/behavior/sunprotection. htm. https://www.ncbi.nlm.nih.gov/pubmed/15837865. https://www.sciencedirect.com/science/article/pii/ S0146280618301889. ... https://www.myeloma.org/diversity/how-myeloma-differentafrican-
-
Why we need to improve diverse representation in clinical trials
In the U.S., the National Institutes of Health (NIH) recently launched its“All of Us” research program, which is an historic effort to gather data from one million or more
-
Solaris Health looks at the gene therapy revolution
https://www.ncbi.nlm.nih.gov/books/NBK1483/ (accessed September 2018). 2.Evaluation consultation document – Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency.
-
Why patient education isn’t simple
www.ncbi.nlm.nih.gov/pubmed/23381513.
-
Living with haemophilia – the power of knowledge
Each week, we are inundated with articles emphasising the importance of regular exercise. On World Hemophilia Day, Porterhouse Medical explores changing attitudes towards exercising with the disease and share guides that help people with haemophilia
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Roche’s Ocrevus boasts positive long-term data in MS
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
